Arnatar Therapeutics

We are a biotechnology company pioneering RNA-based therapeutics to address high unmet medical needs in cardiovascular, metabolic, rare liver, and rare kidney diseases. Our proprietary DARGER™ platform enables both gene upregulation and downregulation using novel antisense oligonucleotide (ASO) and small interfering RNA (siRNA) approaches.